Parallel Advisors, LLC Atara Biotherapeutics, Inc. Transaction History

Parallel Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 20, 2024	BUY	$2.8 - $5.46 $1,761 - $3,434	629 New	629 $1,000
Q1 2023 Apr 25, 2023	SELL	$2.8 - $5.46 $1,167 - $2,276	-417 Reduced 39.87%	629 $1,000
Q4 2022 Feb 03, 2023	BUY	$2.85 - $5.18 $2,664 - $4,843	935 Added 842.34%	1,046 $3,000
Q3 2022 Nov 10, 2022	BUY	$2.85 - $8.73 $316 - $969	111 New	111 $0
Q2 2022 Aug 01, 2022	SELL	$4.69 - $9.84 $975 - $2,046	-208 Closed	0 $0

Q1 2022 Apr 28, 2022	SELL	$8.44 - $16.89 $903 - $1,807	-107 Reduced 33.97%	208 $2,000
Q4 2021 Jan 20, 2022	BUY	$14.7 - $19.89 $1,572 - $2,128	107 Added 51.44%	315 $5,000
Q2 2020 Jul 16, 2020	BUY	$7.53 - $14.93 $1,566 - $3,105	208 New	208 $3,000
Q1 2020 Apr 27, 2020	SELL	$5.69 - $17.78 $301 - $942	-53 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$10.89 - $16.79 $577 - $889	53 New	53 $1,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.